Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3712084010 | Tesamorelin-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3712085011 | Product containing tesamorelin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tesamorelin-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
| Tesamorelin-containing product in parenteral dose form | Is a | Tesamorelin-containing product | true | Inferred relationship | Some | ||
| Tesamorelin-containing product in parenteral dose form | Has active ingredient | Tesamorelin | true | Inferred relationship | Some | 1 | |
| Tesamorelin-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tesamorelin only product in parenteral dose form | Is a | True | Tesamorelin-containing product in parenteral dose form | Inferred relationship | Some | |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Is a | False | Tesamorelin-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR